Pharmaceuticals, Biotechnology and Life Sciences
Sanofi’s Toujeo met the primary study objective in the first large head-to-head clinical trial, called BRIGHT study, comparing Toujeo with insulin…
Texas-headquartered biosciences company XBiotech announced Monday the publication of data from its randomized phase 2 study in which it tested…
Faron Pharmaceuticals has appointed Dr. Juhana Heinonen as Chief Commercial Officer to join the company in January 2018.
Destiny Pharma said on Friday that its development and commercialisation collaboration agreement with CMS Medical Venture Investment Limited, a wholly…
Basilea Pharmaceutica International has amended its existing license agreement for Europe, Russia, Turkey and Israel with Pfizer Inc. for Basilea’s…
STA Pharmaceutical (STA) – a China-based global API and Drug Product CDMO – reports that it has seen a rapid…
ViiV Healthcare on Thursday announced the start of HPTN 084,a phase III study to evaluate long-acting cabotegravir for the prevention of…
Novartis has announced first-of-its-kind long-term data showing that Cosentyx (secukinumab) provided sustained improvements in nail and palmoplantar psoriasis out to…
N4 Pharma, a specialist pharmaceutical company which reformulates existing drugs and vaccines to improve their performance, welcomes the announcement of the…
Circassia Pharmaceuticals welcomes the publication of new clinical guidelines by the UK’s National Institute for Health and Care Excellence (NICE),…